Cost-utility analysis of screening strategies for diabetic retinopathy in Korea

Journal of Korean Medical Science

Volumn 30, Issue 12, 2015, Pages 1723-1732

  Kim, Sang Won ^a   Kang, Gil Won ^b  

^a National Police Hospital   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

Author keywords

Cost utility analysis; Diabetic retinopathy; Markov model; Quality Adjusted Life Years (QALY)

Indexed keywords

ADULT; AGED; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DIABETIC RETINOPATHY; EARLY DIAGNOSIS; ECONOMIC MODEL; ECONOMICS; FEMALE; FLUORESCENCE ANGIOGRAPHY; HEALTH CARE COST; HUMAN; MALE; MARKOV CHAIN; MASS SCREENING; MIDDLE AGED; PROCEDURES; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; SOUTH KOREA; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; VISUAL SYSTEM EXAMINATION;

ADULT; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; DIABETIC RETINOPATHY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; EARLY DIAGNOSIS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEALTH CARE COSTS; HUMANS; MALE; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; MODELS, ECONOMIC; NATIONAL HEALTH PROGRAMS; QUALITY-ADJUSTED LIFE YEARS; REPUBLIC OF KOREA;

EID: 84951760452     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2015.30.12.1723     Document Type: Article

References (22)

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14: S1-85.
2. Lim HT, Choi KS. Factors associated with screening for diabetic retinopathy in diabetic patients aged =40 years using the KNHANES IV. J Korean Ophthalmol Soc 2012; 53: 516-21.
3. Beckles GL, Zhu J, Moonesinghe R, Centers for Disease Control and Prevention (CDC). Diabetes-United States, 2004 and 2008. MMWR Surveill Summ 2011; 60: s90-3.
4. Yudkin JS, Boucher BJ, Schopflin KE, Harris BT, Claff HR, Whyte NJ, Taylor B, Mellins DH, Wootliff AB, Safir JG, et al. The quality of diabetic care in a London health district. J Epidemiol Community Health 1980; 34: 277-80.
5. Lee DW, Park CY, Song SJ. Study on survey of knowledge and awareness level of diabetic retinopathy in type 2 diabetes patients: results from Seoul metro-city diabetes prevention program survey. J Korean Ophthalmol Soc 2011; 52: 1296-301.
6. Jeong H, Kwon H, Han J, Kim Y, Lee A. Cost-effectiveness analysis of type 2 DM screening program of national health insurance corporation. Korean J Health Econ Policy 2008; 14: 29-50.
7. Park SK, Park M-K, Suk JH, Kim MK, Kim YK, Kim IJ, Kang YH, Lee KJ, Lee HS, Lee CW. Cause-of-death trends for diabetes mellitus over 10 years. Korean Diabetes J 2009; 33: 65-72.
8. Jin JH, Lee SJ, Lee HS, Kim SD. Prognostic factors of visual acuity in diabetes mellitus. J Korean Ophthalmol Soc 2006; 47: 755-62.
9. Drummond MF. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 2005.
10. Shin KH, Chi MJ. Fundus examination rate in diabetics and the public health factors associated with fundus examination rate. J Korean Ophthalmol Soc 2009; 50: 1319-25.
11. Kim HK, Oh TS, Lee SM, Lee JB. The initial fundus examination and severity of diabetic retinopathy at a primary eye clinic. J Korean Ophthalmol Soc 2005; 46: 982-8.
12. Maberley D, Walker H, Koushik A, Cruess A. Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis. CMAJ 2003; 168: 160-4.
13. Aoki N, Dunn K, Fukui T, Beck JR, Schull WJ, Li HK. Cost-effectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison population. Diabetes Care 2004; 27: 1095-101.
14. Younis N, Broadbent DM, Vora JP, Harding SP, Liverpool Diabetic Eye Study. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003; 361: 195-200.
15. Blankenship GW. Fifteen-year argon laser and xenon photocoagulation results of Bascom Palmer Eye Institute's patients participating in the diabetic retinopathy study. Ophthalmology 1991; 98: 125-8.
16. Facey K, Cummins E, Macpherson K, Morris A, Reay L, Slattery J. Health technology assessment report 1: Organisations of services for diabetic retinopathy screening. Glasgow: Health Technology Board for Scotland, 2002.
17. Heintz E, Wiréhn AB, Peebo BB, Rosenqvist U, Levin LA. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO. Value Health 2012; 15: 475-84.
18. Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999; 128: 324-30.
19. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R. Retinopathy in diabetes. Diabetes care 2004; 27: s84-7.
20. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005; 46: 2328-33.
21. Usher D, Dumskyj M, Himaga M, Williamson TH, Nussey S, Boyce J.Automated detection of diabetic retinopathy in digital retinal images: a tool for diabetic retinopathy screening. Diabet Med 2004; 21: 84-90.
22. James M, Turner DA, Broadbent DM, Vora J, Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ 2000; 320: 1627-31.